Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole Once-Monthly vs Standard of Care in Non-adherent Schizophrenia
NCT02282085Phase 4Unknown
- Start
- Dec 2014
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in schizophrenia comparing Aripiprazole Once-Monthly with Standard of Care (2 arms). Primary endpoint: Positive and Negative Syndrome Scale total score improvement - response at 3 months. Status: unknown.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02282085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02282085.